Assort Health Raises $120M Series C as Healthcare AI Moves Into Operations

Assort Health, a San Francisco healthcare AI startup building patient journey automation for providers, announced a $120M Series C funding round led by Menlo Ventures. The round values the company at $1.2B and brings total funding to more than $222M. Existing investors, including Lightspeed Venture Partners, Felicis, First Round Capital, Chemistry, Tau Ventures, Quiet Capital, and Joe Montana, also participated.

Founded in 2023 by Co-CEOs Jon Wang and Jeffery Liu, the company builds AI agents for healthcare providers that automate scheduling, referrals, intake, document processing, medication refills, insurance eligibility, payments, and patient outreach. This is not diagnostic AI attempting to read scans or replace clinical judgment. It is operational AI focused on the administrative work that determines whether patients actually move through care efficiently.

Healthcare has no shortage of brilliant physicians, but it has plenty of paperwork with Olympic-level endurance. Assort Health is betting the better investment is not hiring more people to compensate for broken processes. It is fixing the process itself.

What Happened

Assort Health's Series C places the company firmly in the healthcare AI unicorn conversation, but the more meaningful signal is where the capital is going. The company says it has now raised more than $222M since its founding and will use the new funding to expand what it describes as the largest deployment of AI agents for the patient journey. Menlo Ventures is betting that operational AI becomes healthcare infrastructure rather than another standalone software category.

Rather than focusing on a narrow chatbot workflow, Assort Health has built AI agents that coordinate administrative tasks across the front door of care. Its platform manages inbound calls, appointment scheduling, referrals, intake documentation, eligibility verification, payment workflows, medication refill requests, and outbound patient engagement while integrating with provider systems such as Epic and athenahealth. That breadth matters because healthcare operations rarely break in just one place.

The market is increasingly separating companies that demonstrate AI in isolated workflows from those embedding AI into operational infrastructure. Assort Health is positioning itself in the second category. Its thesis is that healthcare organizations need fewer disconnected tools and more systems capable of moving work across the entire patient journey.

Why This Matters

Healthcare organizations rarely lose money because physicians lack expertise. They lose money because operational friction compounds every day. Patients abandon phone calls, referrals disappear into administrative limbo, scheduling delays reduce provider utilization, and staff spend hours moving information between disconnected systems.

Assort Health targets those inefficiencies with a platform trained on more than 190M specialty patient interactions, 62,000 care protocols, and 1.6M decision pathways. According to the company, customers have generated 20x revenue growth over the past 15 months while seeing a 5% increase in appointment volume and a 115% increase in labor capacity. Those figures matter because healthcare AI is entering a phase where investors reward measurable operational outcomes over technical demonstrations.

AI no longer earns credit simply for sounding intelligent. It has to improve utilization, reduce administrative costs, and deliver measurable financial returns that healthcare executives can recognize. That is a much higher standard, and ultimately a healthier one for the industry.

Market Context

Administrative work remains one of healthcare's largest economic burdens, and Assort Health estimates that administrative complexity accounts for roughly $1.1T in annual costs across the U.S. healthcare system. That helps explain why venture capital continues flowing into healthcare workflow automation, patient access, healthcare administration, operational AI, and enterprise AI. The opportunity is not simply making clinicians faster. It is making the entire care journey more efficient.

Specialty-specific data is central to that strategy. Orthopedics is not dermatology, cardiology does not operate like oncology, and general-purpose AI struggles when workflows depend on specialty protocols, local processes, and payer requirements. Companies building proprietary workflow intelligence today are creating competitive advantages that cannot simply be replicated by adopting the latest foundation model.

Competitive Landscape

Healthcare AI has become one of venture capital's busiest markets. Many companies focus on clinical documentation, physician copilots, medical coding, or conversational patient engagement. Assort Health differentiates itself by connecting operational workflows across the patient journey instead of optimizing a single administrative task.

Its product portfolio includes Concierge for inbound patient interactions, Activate for proactive patient outreach, Orchestrate for workflow automation, and Empower as an AI copilot for healthcare staff. That broader orchestration strategy reflects where enterprise AI appears to be heading across industries. The first generation answered questions, the second completed individual tasks, and the emerging generation coordinates entire business processes.

What This Signals

The most interesting part of this round is not the valuation. Unicorns generate headlines, but infrastructure changes markets. Menlo Ventures and the participating investors are effectively betting that healthcare organizations will purchase AI as operational infrastructure rather than another detached productivity layer.

That distinction changes how companies are valued. Infrastructure becomes embedded, embedded systems become difficult to replace, and vendors that become operational dependencies often earn stronger customer retention than companies selling isolated tools. Founders watching this market should recognize that the companies attracting significant institutional capital are solving problems executives already budget to address.

The Bigger Industry Shift

Artificial intelligence spent its first public act trying to impress people. Its second act is trying to disappear into the work. That may sound backward, but it reflects how enterprise technology actually succeeds.

Nobody celebrates the database that keeps payroll running, and nobody applauds the networking equipment moving trillions of dollars every day. Infrastructure succeeds because people stop thinking about it. If patients remember getting appointments faster, providers remember fewer administrative headaches, and executives remember stronger operational performance, very few people will remember the algorithm. That may be the clearest sign that AI has finally become useful.